A study in humans demonstrated that the miR-641 was significantly higher in plaque rupture patients than plaque erosion patients in a replication cohort, though it was lower in ST-segment elevation myocardial infarction patients compared to healthy controls [Li et al. DOI:10.1016/j.ygeno.2020.11.019].